Welcome to the ValueWiki Cephalon, Inc. (CEPH) article! Register for free or click the "edit" link to contribute!    

Cephalon, Inc. (CEPH)

From ValueWiki

Jump to: navigation, search
This summary section needs content! Click Here to begin writing.
Have a question about Cephalon, Inc.? Ask it on the Message Board or Chat Room
Visit the Apple, Inc. page for an example of a complete article.

Contents

Today 5d 3m 6m 1y 2y 5y Max



Funds w/ CEPH: 139
Rank: 214 / 351



Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.[1] Be bold!

News Feed

12/02/08 3:12 pm Earn Great Returns Until 2018 (at Motley Fool)
12/02/08 7:12 am Alkermes to take over anti-alcoholism drug (at bizjournals.com)
12/01/08 5:12 pm CEPHALON INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Material Impairments, Other Event (EDGAR Online)
12/01/08 2:12 pm UPDATE - Alkermes' deal with Cephalon ends; raises '09 view (at Reuters)
12/01/08 12:12 pm Cephalon Making Progress (Zacks.com)
12/01/08 12:12 pm Cephalon ends co-promotion arrangement with Alkermes (at bizjournals.com)
12/01/08 10:12 am Alkermes takes over Vivitrol commercialization (AP)
12/01/08 9:12 am Companies sue Mylan over generic version of Amrix (AP)
11/29/08 8:11 am Cephalon sues to defend Amrix patent (at bizjournals.com)
11/26/08 9:11 pm Cephalon Lashes Out At Copycats (at Forbes.com)
More News...

Risks

This section needs content! Click the blue edit link (to the right) to contribute.

Research Links

Cephalon, Inc. Snapshot
Cephalon, Inc. Leadership
Cephalon, Inc. Fundamentals
Cephalon, Inc. Technical Analysis
Cephalon, Inc. Message Boards

Options

Notes

  1. This is a sample reference.
Personal tools